Evidence map›Paper›PMID 35715807›Full record

SynthesisRespiratory research2022

Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies.

Matthew Moll, Brian D Hobbs, Aravind Menon, Auyon J Ghosh, Rachel K Putman, Takuya Hino, Akinori Hata, Edwin K Silverman, John Quackenbush, Peter J Castaldi and 8 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Respiratory research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.American journal of respiratory and critical care medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Matthew Moll *Channing Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Brian D Hobbs *Channing Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Aravind MenonDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Auyon J GhoshChanning Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Rachel K PutmanDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Takuya HinoHarvard Medical School, Boston, MA, 02115, USA.
Akinori HataHarvard Medical School, Boston, MA, 02115, USA.
Edwin K SilvermanChanning Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
John QuackenbushChanning Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Peter J CastaldiChanning Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Craig P HershChanning Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Michael J McGeachieChanning Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Don D SinCentre for Heart Lung Innovation, St. Paul's Hospital, and Department of Medicine (Respiratory Division), University of British Columbia, Vancouver, BC, Canada.
Ruth Tal-SingerCOPD Foundation, Washington, D.C., USA.
Mizuki NishinoHarvard Medical School, Boston, MA, 02115, USA.
Hiroto HatabuHarvard Medical School, Boston, MA, 02115, USA.
Gary M Hunninghake *Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Michael H Cho *Channing Division for Network Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. remhc@channing.harvard.edu.
Harvard University · USBrigham and Women's Hospital · USCOPD Foundation · USSt. Paul's Hospital · CA

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SILVERMAN, EDWIN K · 2013 to 2025
$24.9M
Integrative Metabolomics of Asthma SeverityR01HL123915 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2014 to 2023
$7.0M
Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)R01HL139634 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MCGEACHIE, MICHAEL JOHN · 2018 to 2022
$4.3M
Omic Determinants of Longitudinal Lung Function in AsthmaR01HL155742 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A, MCGEACHIE, MICHAEL JOHN · 2021 to 2025
$3.9M
Networks Tools to Understand Sex- and Gender-Specific Drivers of DiseaseR01HG011393 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMEO, DAWN L, QUACKENBUSH, JOHN · 2021 to 2024
$2.1M
Multi-omic Subtyping of Chronic Obstructive Pulmonary DiseaseK08HL136928 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HOBBS, BRIAN DANIEL · 2017 to 2021
$864k
NHGRI NIH HHS R01 HG011393NHLBI NIH HHS K08 HL136928NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL123915NHLBI NIH HHS R01 HL139634NHLBI NIH HHS R01 HL155742
6 · The paper itself

Abstract

backgroundInterstitial lung abnormalities (ILA) are radiologic findings that may progress to idiopathic pulmonary fibrosis (IPF). Blood gene expression profiles can predict IPF mortality, but whether these same genes associate with ILA and ILA outcomes is unknown. This study evaluated if a previously described blood gene expression profile associated with IPF mortality is associated with ILA and all-cause mortality.

methodsIn COPDGene and ECLIPSE study participants with visual scoring of ILA and gene expression data, we evaluated the association of a previously described IPF mortality score with ILA and mortality. We also trained a new ILA score, derived using genes from the IPF score, in a subset of COPDGene. We tested the association with ILA and mortality on the remainder of COPDGene and ECLIPSE.

resultsIn 1469 COPDGene (training n = 734; testing n = 735) and 571 ECLIPSE participants, the IPF score was not associated with ILA or mortality. However, an ILA score derived from IPF score genes was associated with ILA (meta-analysis of test datasets OR 1.4 [95% CI: 1.2-1.6]) and mortality (HR 1.25 [95% CI: 1.12-1.41]). Six of the 11 genes in the ILA score had discordant directions of effects compared to the IPF score. The ILA score partially mediated the effects of age on mortality (11.8% proportion mediated).

conclusionsAn ILA gene expression score, derived from IPF mortality-associated genes, identified genes with concordant and discordant effects on IPF mortality and ILA. These results suggest shared, and unique biologic processes, amongst those with ILA, IPF, aging, and death.

Indexed as

Idiopathic Pulmonary FibrosisLung Diseases, InterstitialCohort StudiesHumansLungTomography, X-Ray ComputedTranscriptome

Identifiers

PMID35715807
PMCPMC9204872
OpenAlexW4283077626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.